on BASTIDE (EPA:BLC)
The Bastide Group sells its subsidiary EXPERF to Sapio Group
On May 21, 2026, the Bastide Group announced the sale of its subsidiary New Medical Concept, the holding company of the EXPERF Group, to Sapio Group. EXPERF, part of the Bastide Group since 2017, doubled its revenue, reaching €42 million for the 2024-2025 fiscal year.
The sale is part of Bastide's asset optimization strategy. This transaction should help reduce the group's debt by improving its leverage ratio to slightly above 2.5x. The projected revenue of €510 million for the current fiscal year will not be affected.
Sapio, which is rapidly expanding in the healthcare sector, sees this acquisition as a key driver of its strategy in France. The completion of this transaction remains subject to customary closing conditions.
R. P.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all BASTIDE news